USA flag logo/image

An Official Website of the United States Government

MULTIPLEXED SENSITIVE TESTING FOR DRUGS OF ABUSE

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
96549
Program Year/Program:
2010 / SBIR
Agency Tracking Number:
N43DA201000012
Solicitation Year:
N/A
Solicitation Topic Code:
NIDA
Solicitation Number:
N/A
Small Business Information
BIOMEDOMICS, INC.
6 DAVIS DRIVE RESEARCH TRIANGLE PARK, NC 27709
View profile »
Woman-Owned: No
Minority-Owned: Yes
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2010
Title: MULTIPLEXED SENSITIVE TESTING FOR DRUGS OF ABUSE
Agency: HHS
Contract: N43DA201000012
Award Amount: $99,989.00
 

Abstract:

Most drugs of abuse (DOA) testing is performed in a central lab that requires the shipping of specimens, expensive equipment (GC/MS/LS), long turnaround times, and uses valuable staff resources with current testing. Current DOA point of care (POC) assays used as pre-screening assays are generally not as sensitive or accurate as GC/MS/LS, and often times requires extra staff according to specific guidelines.

Principal Investigator:

Frank Wang
Small Business Information at Submission:

BIOMEDOMICS, INC.
6 DAVIS DRIVE RESEARCH TRIANGLE PARK, NC 27709-

EIN/Tax ID: 205795824
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: Yes
HUBZone-Owned: No